BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) NanoAb May Serve as Therapeutic and Prophylactic as Shown in Preclinical Study
Jan 23, 2023
BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, today announced additional results in a preclinical proof-of-concept study of its innovative inhaled NanoAb COVID-19 drug. According to the update, the study used an industry-standard animal model to compare weight loss in two groups of hamsters. Hamsters administered a mid-sized 0.66mg dose of the NanoAb three hours prior to infection experienced no significant weight loss over the six-day trial, whereas the untreated control group’s weight declined 12% on average, a highly statistically significant difference (p<0.0005). “We continue to be thrilled with the results of this ongoing trial,” said BiondVax’s CEO Amir Reichman. “There is strong market demand for COVID prophylactics as evidenced by AstraZeneca’s reported Q1 through Q3 2022 EVUSHELD revenues of $1.5 billion*. EVUSHELD is currently the only prophylactic COVID medication with FDA approval, under emergency use authorization. Our inhaled NanoAb is designed to be self-administered at the time of choosing to generate rapid protection from COVID illness. In contrast, EVUSHELD must be administered via two separate consecutive intramuscular (‘IM’) injections in a health care setting, and the FDA has confirmed it does not effectively neutralize recent Omicron variants of concern.** Data from our trial indicate that our NanoAb may effectively serve as both a therapeutic and protective prophylactic drug, which further enhances its value proposition.”
To view the full press release, visit https://nnw.fm/ZM06t
About BiondVax Pharmaceuticals Ltd.
BiondVax is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. Since its inception, BiondVax has executed eight clinical trials including a seven-country, 12,400-participant phase 3 trial of its prior vaccine candidate and has built a state-of-the-art manufacturing facility for biopharmaceutical products. With highly experienced pharmaceutical industry leadership, BiondVax is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (“NanoAb”) pipeline. For more information, visit the company’s website at www.BiondVax.com.
*https://www.astrazeneca.com/media-centre/press-releases/2022/year-to-date-and-q3-2022-results.html
NOTE TO INVESTORS: The latest news and updates relating to BVXV are available in the company’s newsroom at https://ibn.fm/BVXV
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork.
More News
Elon Musk's millions fail to deliver Texas for the Republicans in fierce midterms
The billionaire's political action committee (Pac) contributed $47m (£35m) to Ken Paxton's campaign.
Sony PS5 trade-in offer: US gamers can get up to $400 for old consoles ahead of GTA 6 launch; check details
Sony is offering US gamers up to $400 in cash for trading in their old PlayStation 5 consoles through a partnership with refurbished electronics marketplace Back Market, according to TweakTown. The offer could help players upgrade to the $899.99 PS5 Pro ahead of the much-anticipated GTA 6 launch.
SpaceX teams up with Qualcomm to expand the Starlink 5G network
SpaceX teams up with Qualcomm to expand the Starlink 5G networkQualcomm has secured an extended contract with SpaceX to supply radio equipment, baseband units and software for Starlink Mobile’s planned countrywide ground-based 5G infrastructure as the Elon Musk-led space company aims to...
Central cyber security agency warns banks, fintech firms of frauds through AI agents
Central cyber security agency warns banks, fintech firms of frauds through AI agents
How Democratic sweep could slow AI growth in US – and help China’s ambitions
The Democratic Party’s sweeping midterm election victory and takeover of both houses of Congress could slow down the pace of artificial intelligence development in the US, with implications for both the global AI trade and the technology rivalry between Washington and Beijing, analysts said. The assessment comes as concerns about AI and the data centres that power it proved to be a contributing factor in the backlash against the Republican Party and US President Donald Trump, a vocal supporter...
The pickle in your sandwich, the oat milk in your coffee or even the beetroot on your salad, nutritionist reveals the 'hidden sugars' impacting your health
Food nutritionist Aaliyah Nelson has revealed the 'hidden sugars' that crop up in the foods you'd least expect.
Doomed 3,200-pound NASA telescope to crash back to Earth tomorrow as map reveals possible impact zones
NASA is monitoring the uncontrolled re-entry of a space telescope that will crash back to Earth sometime on Wednesday.
NASA's Voyager 1 nears historic milestone: It will soon be one light-day away from Earth
Nearly 5 decades after its launch, NASA's Voyager 1 is approaching a historic one-light-day milestone, putting it more than 16 billion miles from Earth. As the spacecraft moves deeper into space, engineers are battling declining power, ageing equipment and unexpected communication disruptions.
DeepSeek engineer defends push for open-source AGI despite higher risks
DeepSeek is committed to open-source artificial intelligence to accelerate the arrival of artificial general intelligence (AGI), even if it heightens safety risks, a company engineer says, defying growing safety concerns from the US and scrutiny in China over whether the strategy poses national security risks. Speaking on Tuesday on an AI panel at the World Internet Conference (WIC) in Wuzhen, DeepSeek engineer Gao Xi said open-source development promoted shared innovations and technical...
William meets firefighters who tackled summer blazes
The prince says 2026 was the first summer he felt "worried about the scale of the wildfires".
Britain's first Roman capital was surprisingly cosmopolitan: Ashes suggest Colchester was a 'melting pot' that attracted people from Italy, Spain and Lebanon
Britain's first Roman capital was a bustling multicultural hub that attracted visitors from across the empire, according to a new study.
Do mosquito repellent patches work? Experts weigh in on the buzz
As West Nile virus concerns rise, some are turning to essential oil patches for easy bite prevention.
Recommended
Polar vertex: How does it impact UK weather?
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.